Novavax (NASDAQ:NVAX) has been a big winner for investors since the beginning of the pandemic. However, concerns about delays in regulatory filings for the company’s COVID-19 vaccine candidate …
https://www.fool.com/investing/2021/10/22/whats-the-outlook-for-novavax-stock/

